Advertisement

The Latest

Controlled substance waste is one of the most overlooked cost centers in hospital pharmacy. Each waste event represents not just a lost dose, but lost nursing time, compliance overhead and real diversion risk. A recent multi-site study quantified the problem:…

On Demand

Presented by:

Presented by
Presenters:
  • Matthew Gimbar, PharmD
  • Paul Stranges, PharmD, MSHI, BCACP, AE-C, FCCP
  • John Hertig, PharmD, MS, CPPS, FASHP, FFIP

UCLA Health researchers are developing wearable technology to detect early signs of autism and other developmental conditions in infants.  The project, supported by a $3.1 million grant from the National Institute of Neurologic Disorders and Stroke, will test wearable sensors…

Between the July 2022 launch of the 988 Suicide and Crisis Lifeline and December 2024, 35,529 suicides were observed compared to 39,901 expected, representing an 11% reduction, or 4,372 fewer deaths, according to an April 22 research letter published in JAMA. …

CareSource said it will retroactively recoup Medicaid payments from some Ohio behavioral health providers and reduce future reimbursements to 85% from 100%, ABC affiliate WCPO 9 reported April 22. The changes apply to both new claims and payments already made…

After piloting its Just In Time prescriber scheduling system, Yakima, Wash.-based Comprehensive Healthcare appointment show rates rose from 58.5% in November 2025 to 70% in January, while cancellations declined from 31% in November to 19% in early April.  The model…

Stamford, Conn.-based Cohen Veterans Network opened its first mental health clinic in Kansas on April 23.  The Steven A. Cohen Military Family Clinic at Centerstone in Manhattan, began serving post-9/11 veterans, service members and their families across the state, providing…

Oxford Treatment Center in Etta, Miss., reported a 35% increase in patients identifying alcohol as their primary substance of concern over the past year.  The trend reflects a broader public health issue, as alcohol use disorder affects approximately 1 in…

The FDA is issuing national priority vouchers to three companies studying psychedelic drugs to treat serious mental illness.  The vouchers were issued to companies studying psilocybin for treatment-resistant depression and major depressive disorder as well as methylone for post-traumatic stress…

Pharmacy is no longer a cost center defending its budget. It is an enterprise lever, and the executives running it are being asked to behave — and be staffed — accordingly. At the 2026 CPO Summit, the chief pharmacy officers…

Advertisement